Lv5
1230 积分 2023-07-05 加入
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
3小时前
待确认
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
4天前
已完结
From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer
17天前
已完结
Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor–Positive Early Breast Cancer: A Nationwide Cohort Study
18天前
已完结
Time-varying pattern of recurrence risk for Chinese breast cancer patients
1个月前
已完结
Practical recommendations for using ctDNA in clinical decision making
1个月前
已完结
Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer
1个月前
已完结
RT-qPCR is helpful to distinguish the clinicopathological features of HER2 immunohistochemistry 0 and 1 +
1个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
1个月前
已完结
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
2个月前
已完结
皖公网安备34019202002308
